The end-use landscape of the Medical Oxygen Concentrator Market is clearly defined, with hospitals and clinics representing the largest segment, holding a 58% share. Hospitals are the primary settings for acute respiratory care, managing patients with severe respiratory distress, post-operative oxygen needs, and acute exacerbations of chronic conditions. They have the resources, specialized staff, and infrastructure to support high-flow oxygen therapy and manage complex cases.

Hospitals' dominance is driven by the high volume of respiratory conditions treated in inpatient settings. Emergency departments, intensive care units, and medical-surgical units all require reliable oxygen delivery systems. Hospitals typically purchase stationary oxygen concentrators in bulk, benefiting from economies of scale and ensuring consistent availability of medical-grade oxygen. The presence of respiratory therapists and specialized pulmonary care teams supports the effective use of oxygen therapy in these settings.

While hospitals dominate, homecare settings are the fastest-growing end-use segment, reflecting a broader shift toward patient-centered care and cost containment. Patients increasingly prefer to receive oxygen therapy in their homes, avoiding hospital stays and the associated risks and costs. Advances in oxygen concentrator technology have made home use more feasible, with lightweight, portable devices and user-friendly interfaces enabling patients to manage their therapy independently.

The growth of homecare settings is driven by several factors. First, the aging population prefers to age in place, creating demand for home-based respiratory care solutions. Second, healthcare systems are increasingly recognizing the cost savings associated with home care, as it reduces hospital readmissions and long-term care facility utilization. Third, technological innovations, including remote monitoring capabilities and smart connectivity, are improving the safety and effectiveness of home oxygen therapy.

In Q2 2025, O2 Concepts raised USD 40 million in Series C funding to accelerate innovation in portable oxygen devices for homecare. In Q1 2025, Philips launched a remote monitoring platform enabling healthcare providers to track patients using its oxygen concentrators, improving outcomes and reducing hospital readmissions. As these trends continue, the homecare segment is expected to capture an increasing share of the medical oxygen concentrator market.